ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.
The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...
The field of gene and cell therapy has entered a period of rapid advancement. From CRISPR-Cas9–based genome editing to the clinical application of ...
A scientific breakthrough not only promises faster testing for antimicrobial resistance, but also an ethical solution to the ...
CRISPR Therapeutics (NASDAQ:CRSP) is a gene editing company that develops gene-based medicines for serious human diseases ...
Researchers have developed a new biomimetic nanocomposite (mPDA-Cas9) for treating triple-negative breast cancer (TNBC) by combining CRISPR/Cas9 gene ...
OGM was selected as a genome-wide, unbiased method to detect large genomic rearrangements and structural variants (SVs) with sensitivity to variant allele fractions (VAFs) as low as 5% to analyze ...
Venkatesan Sundaresan, a distinguished professor of plant biology and plant sciences at UC Davis, has been awarded a Gates Foundation grant to develop self-cloning crops for Indian farmers.The ...
Advancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testing
Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced ...
Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing technology. In a landmar.
Scientists have uncovered a 400-million-year-old genetic secret that gave spiders the ability to produce silk and weave their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results